Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques

Dry powder inhaler, Nanopharm, OINDPs

03 Dec 2025

Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques

Download the Microstructural Characterization of Dry Powder Inhaler Formulations Publication

Articles

ISAM 2026: Looking Forward to the Next Chapter for Inhaled and Nasal Drug Delivery

Key takeaways from ISAM 2026: Nanopharm’s Lucas Silva on inhaled biologics, digital health and regulatory science in nasal and pulmonary drug delivery.

August 18, 2026 No Comments

Inhalation

NBO Pharma See The Immediate Benefits of An Integrated Approach to Intranasal Product Development with The Aptar Pharma Family of Services

NBO Pharma see the immediate
benefits of an integrated approach to
intranasal product development with
the Aptar Pharma family of services

August 17, 2026 No Comments

Articles

Balancing Creativity with Compliance: Meet Kirsten Searle, Manager of Pharma Development

Discover how Kirsten Searle is enhancing project management excellence at Nanopharm. Hear about her philosophy on balancing pragmatic process with scientific innovation in a fast-paced CRO environment.

July 6, 2026 No Comments

About Us

Product Development

Analytical Services

In-Silico Modeling

Regulatory

Nasal

Inhalation

Inhaled Biologics

Generics & Lifecycle Management

Resources

03 Dec 2025

Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques

Related Posts

ISAM 2026: Looking Forward to the Next Chapter for Inhaled and Nasal Drug Delivery

NBO Pharma See The Immediate Benefits of An Integrated Approach to Intranasal Product Development with The Aptar Pharma Family of Services

Balancing Creativity with Compliance: Meet Kirsten Searle, Manager of Pharma Development